Literature DB >> 23105677

Tumour markers: An overview.

T Malati1.   

Abstract

Tumor Markers comprise a wide spectrum of biomacromolecules synthesized in excess concentration by a wide variety of neoplastic cells. The markers could be endogenous products of highly active metabolic malignant cells or the products of newly switched on genes, which remained unexprssed in early life or newly acquired antigens at cellular and sub-cellular levels. The appearance of tumor marker and their concentration are related to the genesis and growth of malignant tumors in patients. An ideal tumor marker should be highly sensitive, specific, reliable with high prognostic value, organ specificity and it should correlate with tumor stages. However, none of the tumor markers reported to date has all these characteristics. Inspite of these limitations, many tumor markers have shown excellent clinical relevance in monitoring efficacy of different modes of therapies during entire course of illness in cancer patients. Additionally, determination of markers also helps in early detection of cancer recurrence and in prognostication.

Entities:  

Keywords:  Cancer progression; Carcinogenesis; Malignancy; Prognostic Value; Tumor Markers

Year:  2007        PMID: 23105677      PMCID: PMC3453798          DOI: 10.1007/BF02913308

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  80 in total

1.  New monoclonal antibodies identify the glycoprotein carrying the CA 125 epitope.

Authors:  T J O'Brien; L M Raymond; G A Bannon; D H Ford; H Hardardottir; F C Miller; J G Quirk
Journal:  Am J Obstet Gynecol       Date:  1991-12       Impact factor: 8.661

2.  Epidermal growth factor receptors in breast cancer: association with early relapse and death, poor response to hormones and interactions with neu.

Authors:  A L Harris; S Nicholson; J R Sainsbury; J Farndon; C Wright
Journal:  J Steroid Biochem       Date:  1989       Impact factor: 4.292

3.  Alpha-fetoprotein-producing renal cell carcinoma.

Authors:  H Morimoto; N Tanigawa; H Inoue; R Muraoka; Y Hosokawa; T Hattori
Journal:  Cancer       Date:  1988-01-01       Impact factor: 6.860

4.  Human -fetoprotein. Isolation, characterization, and demonstration of microheterogeneity.

Authors:  E Alpert; J W Drysdale; K J Isselbacher; P H Schur
Journal:  J Biol Chem       Date:  1972-06-25       Impact factor: 5.157

Review 5.  Calcitonin: physiology and pathophysiology.

Authors:  L A Austin; H Heath
Journal:  N Engl J Med       Date:  1981-01-29       Impact factor: 91.245

6.  Biochemical diagnosis of pheochromocytoma by simultaneous measurement of urinary excretion of epinephrine and norepinephrine.

Authors:  G A Smythe; G Edwards; P Graham; L Lazarus
Journal:  Clin Chem       Date:  1992-04       Impact factor: 8.327

7.  Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma.

Authors:  J Holmgren; L Lindholm; B Persson; T Lagergård; O Nilsson; L Svennerholm; C M Rudenstam; B Unsgaard; F Yngvason; S Pettersson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-19

8.  Application of tumor markers in ovarian malignancies.

Authors:  T Malati; G R Kumari; B Yadagiri
Journal:  Indian J Clin Biochem       Date:  2001-07

9.  Racial and ethnic variation of PSA in global population: Age specific reference intervals for serum prostate specific antigen in healthy South Indian males.

Authors:  T Malati; G Rajani Kumari
Journal:  Indian J Clin Biochem       Date:  2004-01

10.  Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas.

Authors:  H M Davis; V R Zurawski; R C Bast; T L Klug
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

View more
  42 in total

1.  [Anaplastic large-cell lymphoma CD30(+) ALK(+)].

Authors:  L Kollarikova; M Heizerova; M Simaljakova
Journal:  Hautarzt       Date:  2016-04       Impact factor: 0.751

Review 2.  Clinically feasible approaches to potentiating cancer cell-based immunotherapies.

Authors:  V I Seledtsov; A G Goncharov; G V Seledtsova
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study.

Authors:  Miao Yu; Yun-Hong Wang; Ahmed M E Abdalla; Wen-Qi Liu; Fei Mei; Jian Wang; Chen-Xi Ouyang; Yi-Qing Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-10-16

4.  Organ Specific Tumor Markers: What's New?

Authors:  Kannan Vaidyanathan; D M Vasudevan
Journal:  Indian J Clin Biochem       Date:  2011-11-08

5.  Association between serum carcinoembryonic antigen level and oxidative stress parameters among diabetic females.

Authors:  Marghoob Hasan; Abdelmarouf Mohieldein
Journal:  Int J Clin Exp Med       Date:  2015-04-15

6.  Evaluation of the clinical application of multiple tumor marker protein chip in the diagnostic of lung cancer.

Authors:  Xiaochuan Wang; Yi Zhang; Liangqi Sun; Shuaiping Wang; Jing Nie; Wenqing Zhao; Guobao Zheng
Journal:  J Clin Lab Anal       Date:  2018-05-07       Impact factor: 2.352

7.  Comparison of deep learning and human observer performance for detection and characterization of simulated lesions.

Authors:  Ruben De Man; Grace J Gang; Xin Li; Ge Wang
Journal:  J Med Imaging (Bellingham)       Date:  2019-06-21

8.  Post-operative unadjuvanted therapeutic xenovaccination with chicken whole embryo vaccine suppresses distant micrometastases and prolongs survival in a murine Lewis lung carcinoma model.

Authors:  Jan Aleksander Kraśko; Karolina Žilionytė; Adas Darinskas; Neringa Dobrovolskienė; Agata Mlynska; Svetlana Riabceva; Iosif Zalutsky; Marina Derevyanko; Vladimir Kulchitsky; Olga Karaman; Natalia Fedosova; Tatiana Vasyliyvna Symchych; Gennady Didenko; Vasyl Chekhun; Marius Strioga; Vita Pašukonienė
Journal:  Oncol Lett       Date:  2018-02-05       Impact factor: 2.967

9.  Dual detection of cancer biomarker CA125 using absorbance and electrochemical methods.

Authors:  Israa Al-Ogaidi; Zoraida P Aguilar; Savan Suri; Honglei Gou; Nianqiang Wu
Journal:  Analyst       Date:  2013-10-07       Impact factor: 4.616

10.  Is Salivary Sialic Acid a Reliable Biomarker in the Detection of Oral Potentially Malignant Disorder and Oral Squamous Cell Carcinoma.

Authors:  Diana Daniel; Jerin Jose; A Harish Kumar
Journal:  J Maxillofac Oral Surg       Date:  2019-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.